MYRIAD GENETICS, INC. Foreign Currency Transaction Gain (Loss), before Tax
MYRIAD GENETICS, INC. (MYGN) reported Foreign Currency Transaction Gain (Loss), before Tax of -$1.10 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2025-02-28
- MYRIAD GENETICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$1.10M.
- MYRIAD GENETICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$3.40M, a 1800.00% decline from fiscal 2022.
- MYRIAD GENETICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was $200.00K.
- MYRIAD GENETICS, INC. foreign currency transaction gain (loss), before tax for fiscal 2021 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|
| 2024-12-31 | -$1.10M 10-K · filed 2025-02-28 | ||
| 2023-12-31 | -$3.40M 10-K · filed 2025-02-28 | ||
| 2022-12-31 | $200.00K 10-K · filed 2024-02-28 | $0.00 10-K · filed 2023-03-01 | |
| 2021-12-31 | $0.00 10-K · filed 2023-03-01 | ||
| 2020-12-31 | $1.00M 10-K · filed 2023-03-01 | ||
| 2020-06-30 | $0.00 10-K · filed 2023-03-01 | ||
| 2019-06-30 | $0.00 10-K · filed 2022-02-25 | ||
| 2018-06-30 | $0.00 10-KT · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |